Saturday 17 October 2026 Export SONM’s income statement to Excel — free account

DNA X, Inc.

DNA X, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $58.3 million, down 37.7% from fiscal 2023. In the quarter to June 2026, revenue grew 7.94%, EPS grew 93.5% and free cash flow grew 59.0%, each against the same quarter a year earlier.

3.27 0.04 +1.24%

Follow SONM

Alert me

Market cap: $4.8M
P/E: 0.0×
Fwd P/E: 4.0×
Dividend yield: —
F-score: 2/9
Altman Z: −8.93
Beneish M: −2.55
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 22.27%

Capital & Financial Ratios $m

Market Cap 4.81

Revenue 59.11

Net Income (8.55)

Free Cash Flow (11.29)

Net Debt (0.90)

Current Ratio 0.57

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E 4.00

P/S ratio 0.07

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth —

Next Y EPS Growth 127.81%

Next Y revenue growth 123.16%

Next 5Y EPS Growth 25.00%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 5.13%

10-year low 10-year high

EV/Sales against its own 10 years 19.39%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	9	5	1	1
Receivables	26	12	—	1
Inventory	7	11	—	—
Other	—	27	27	—
	44	32	29	3

	2023	2024	2025	Q'26
Payables	20	1	4	1
ST’ Debt	—	—	—	—
Other	—	43	38	1
	32	44	48	5

Compound Annual Growth %

	10y	5y	3y
Sales	—	(12.89%)	2.23%
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	17	11	16	—	—
’24	17	12	15	15	58
’23	26	27	28	13	94
’22	13	12	20	24	70
’21	12	12	14	16	55
’20	13	21	14	16	64
’19	26	44	29	17	116

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(3)	(2)	—	—	—
’25	(10)	(5)	(7)	(2)	(24)
’24	0	(3)	0	(5)	(8)
’23	(4)	1	0	0	(4)
’22	(1)	1	(10)	(2)	(12)
’21	(8)	(7)	(6)	(18)	(38)
’20	1	5	(6)	(10)	(11)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	0	(2)	—	—	—
’25	(10)	(5)	(7)	(2)	(24)
’24	0	(3)	(1)	(5)	(9)
’23	(4)	1	0	0	(4)
’22	(1)	1	(10)	(2)	(12)
’21	(8)	(7)	(6)	(18)	(39)
’20	1	5	(6)	(10)	(11)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	5.01	(0.92)	—	—	—
’25	1.44	(14.21)	(4.83)	(11.02)	(28.58)
’24	(12.59)	(25.36)	(9.35)	(81.87)	(128.37)
’23	0.99	1.80	1.80	(5.40)	(0.38)
’22	(68.34)	(39.57)	(7.19)	27.59	(88.13)
’21	(251.80)	(179.86)	(235.61)	(64.75)	(733.81)
’20	(863.31)	(395.68)	(179.86)	(179.86)	(1.17k)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	3,780.00	756.00	156.60	72.00	72.90	41.76	2.52	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	32,864.40	7,056.00	3,060.00	284.40	234.00	192.60	114.84
People
People	Employees	—	—	321	501	317	102	77	92	160	8
	Revenue/emp, $m	—	0.00	0.42	0.23	0.20	0.54	0.91	1.02	0.36	0.00
Income, $m
Income, $m	Revenue	—	59	136	116	64	55	70	94	58	—
	Gross margin, %	—	34.41	35.45	29.68	23.77	11.75	16.65	20.64	17.02	—
	EBT	—	(8)	2	(24)	(30)	(38)	(14)	0	(3)	(8)
	EBT margin, %	—	(14.20)	1.50	(21.03)	(47.59)	(70.48)	(19.91)	0.30	(4.95)	0.00
	Net income	—	0	1	(26)	(30)	(39)	(14)	0	(34)	(21)
	Depreciation	—	1	2	4	3	2	2	2	4	4
Per share, $
Per share, $	Revenue	—	29.49	71,402.63	11,286.50	2,489.96	1,037.45	434.79	392.75	222.43	0.00
	Earnings	—	(7.67)	666.31	(2,500.00)	(1,169.06)	(733.81)	(88.13)	(0.38)	(128.67)	(28.58)
	Cash flow	—	(4.45)	2,032.11	(3,254.66)	(410.89)	(731.48)	(76.96)	(17.00)	(32.38)	(32.55)
	Capex	—	0.00	(1,339.47)	(131.65)	(0.43)	(0.87)	(0.05)	(0.15)	(0.82)	0.00
	Free cash flow	—	(4.45)	692.63	(3,386.31)	(411.32)	(732.36)	(77.01)	(17.15)	(33.19)	(32.55)
	Book value	—	(4.75)	2,699.47	2,478.16	1,105.45	354.18	124.81	93.83	(21.75)	(11.01)
	Shares, m	—	2	0	0	0	0	0	0	0	1
Valuation, ×
Valuation, ×	P/E	—	2.25	2.25	0.00	0.00	0.00	0.00	0.00	0.00	—
	P/S	—	1.21	1.21	0.58	0.52	0.16	0.18	0.35	0.26	—
	P/B	—	283.06	283.06	2.64	1.18	0.47	0.62	1.45	0.00	—
	EV/Sales	—	1.23	1.23	0.57	0.18	(0.04)	(0.01)	0.25	0.16	—
	EV/FCF	—	81.21	81.21	(1.90)	(1.11)	0.06	0.05	(5.64)	(1.11)	—
Cash, $m
Cash, $m	Operating cash flow	—	(9)	4	(34)	(11)	(38)	(12)	(4)	(8)	(24)
	Capex	—	(1)	(3)	(1)	0	0	0	0	0	—
	Free cash flow	—	(9)	1	(35)	(11)	(39)	(12)	(4)	(9)	(24)
Balance, $m
Balance, $m	Working capital	—	(1)	16	20	25	15	12	12	(12)	(19)
	Total debt	—	11	14	10	0	0	0	—	—	—
	Net debt	—	9	0	(1)	(22)	(11)	(13)	(9)	(5)	(1)
	Shareholders’ equity	—	(10)	5	26	28	19	20	22	(6)	(8)
Returns, %
Returns, %	ROA	—	(31.47)	(26.36)	(42.07)	(56.60)	(84.52)	(29.73)	(0.16)	(70.26)	(49.40)
	ROIC	—	0.00	60.31	(57.30)	(275.79)	(312.06)	(127.97)	2.47	0.00	0.00
	ROE	—	36.22	20.94	(168.55)	(110.99)	(164.23)	(72.85)	(0.42)	(403.74)	302.56

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2024 · latest quarter Sep 2025

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CISO CISO Global, Inc.	$8.0M	— (loss-making)	— (loss-making)	−13.73% (below 0%: shrinking)	n/m	+97.08% (above 0%: growing)	24.57%	(25.68%)	Compare
AUID authID Inc.	$5.4M	— (loss-making)	—	−66.04% (below 0%: shrinking)	n/m	−9.52% (below 0%: shrinking)	100.00%	(827.42%)	Compare
CYAB Cyabra, Inc.	$5.2M	— (loss-making)	—	—	n/m	+6.09% (above 0%: growing)	83.59%	(168.38%)	Compare
FAASF DigiAsia Corp.	$4.9M	— (loss-making)	—	—	n/m	−2,135.68% (below 0%: shrinking)	—	0.00%	Compare
SONM DNA X, Inc.	$4.8M	— (loss-making)	4.0×	+7.94% (above 0%: growing)	n/m	+59.01% (above 0%: growing)	0.00%	0.00%
MARK Remark Holdings, Inc.	$4.4M	— (loss-making)	11.9×	+74.86% (above 0%: growing)	n/m	+76.25% (above 0%: growing)	66.56%	(3,139.06%)	Compare
YYAI AiRWA Inc.	$3.5M	— (loss-making)	—	+608.13% (above 0%: growing)	n/m	−56.39% (below 0%: shrinking)	26.55%	(1.40%)	Compare
TAOP Taoping Inc.	$3.2M	— (loss-making)	4.9×	+119.09% (above 0%: growing)	n/m	−34.14% (below 0%: shrinking)	27.52%	0.00%	Compare
CETX Cemtrex Inc.	$3.1M	0.0×	— (loss-making)	+8.69% (above 0%: growing)	n/m	−112.80% (below 0%: shrinking)	41.74%	(6.47%)	Compare
Median of peers	$4.6M	—	—	+41.78%	—	−21.83%	41.74%	(16.07%)

All 173 Software Infrastructure stocks →

DNA X, Inc. (SONM) key facts

Concern: DNA X, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $58.3 million, down 37.7% from fiscal 2023.
DNA X, Inc. (SONM) is a Software Infrastructure company in the Technology sector, listed on Nasdaq.
As of October 16, 2026, SONM traded at $3.27, a market capitalization of $4.8 million.
Return on equity was 302.6% and debt-to-equity 0.00.
Its Piotroski F-score is 2 out of 9 and its Altman Z-score is −8.93 (distress zone) for fiscal 2024.

Source: company filings (standardised) and stockrow calculations.